Case Report Form Start-up Meeting March 25, 2010 Kingston, ON.

Slides:



Advertisements
Similar presentations
Adverse Drug Events (ADEs)
Advertisements

Module 6: Case Report Form (Chart Abstraction). This training session contains information regarding: Overview the CRF Overview the CRF Highlights of.
1 Year 2 Highlights MARC MARC-35 Sites: Year 2.
CMS Core Measures Evidence-Based Performance Measurement.
The REDOXS © Study REducing Deaths from OXidative Stress Sponsor Dr. Daren Heyland, MD, FRCPC Project Leader Rupinder Dhaliwal, BASc, RD.
The REDOXS © Study REducing Deaths from OXidative Stress Study Chair Dr. Daren Heyland, MD, FRCPC Project Leader Rupinder Dhaliwal, BASc, RD.
The REDOXS © Study REducing Deaths from OXidative Stress PART 4 of 4 Sponsor Dr. Daren Heyland, MD, FRCPC Project Leader Rupinder Dhaliwal, BASc, RD.
Developing a Phase II RCT: The effects of n-3 fatty acids on lung and systemic inflammation in patients with acute lung injury Renee Stapleton 7/07/05.
QUESTIONS AND ANSWERS. A patient is admitted to the surveillance specialty with a catheter in situ Are they included in CAUTI surveillance?
NOSOCOMIAL INFECTION SURVEILLANCE METHODS Masud Yunesian, M.D., Epidemiologist.
6th June 2004 By Norah A A Al Khathlan M.D. JOURNAL CLUB A Comparison of High-Dose and Standard-dose Epinephrine in Children with Cardiac Arrest NEJM 350;17April.
Coordinator Training Session: March 11, 2012 Major Changes in Data EntryMyers 1 What is the same? What is reduced/removed? What is added/expanded? INTERMACS.
Intensive versus Conventional Glucose Control in Critical Ill Patients N Engl J Med 2009; 360: 雙和醫院 劉慧萍藥師.
Collecting data in clinic.  Aim of BADBIR  Definition of Adverse Events  Adverse events in BADBIR  Adverse event recording in hospital case notes.
A RandomizEd Trial of ENtERal Glutamine to MinimIZE Thermal Injury Study Sponsors Dr. Paul Wischmeyer (US) Dr. Dominique Garrel (Canada) Clinical Evaluation.
Instructions and Reporting Requirements Module 7 Electronic Reporting For Facilities March 2014 North Carolina Central Cancer Registry State Center for.
Study Procedures & Operational Issues Start-up Meeting March 25, 2010 Kingston, ON.
INIS in practice. Recruitment Ideas for boosting recruitment in your unit Raising awareness of INIS on your unit Dealing with staff antagonism Coordinating.
Mortality review Brian Bjørn, M.D. International Forum on Quality Improvement in Health Care Paris – April 9, 2014 Danish Society for Patient Safety.
Module 3: Informed Consent. This training session contains information regarding: Documenting consent Documenting consent Conducting informed consent.
Patient Hand-Offs Sheri S. Crow, MD, MS Assistant Professor of Pediatrics Critical Care Medicine Mayo Clinic Rochester, MN.
Clinical Assessment Program for Residencies Jim Czarnecki, D.O.
“One of America’s Best Hospitals” – U.S. News & World Report Medication Reconciliation JCAHO Patient safety Goal #8.
Infection Adjudication on REDCAP Module 1 Version: Feb 1st, 2012.
Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU) Screening and randomisation Mette Krag Dept. of Intensive Care 4131 Copenhagen University.
Critical Appraisal (CA) I Prepared by Dr. Hoda Abd El Azim.
Mette Krag, MD, coordinating investigator
Module 4: Central Randomization System (CRS). This training session contains information regarding: Overview of Data Collection & Entry Overview of Data.
REDOXS Training: Introduction & Site Investigator
Copenhagen University Hospital Rigshospitalet, Denmark
Serious Adverse Event Reporting Start-up Meeting March 25, 2010 Kingston, ON.
General Instructions for CRF 3 Rev H To be completed at each follow up visit Patient Identification and Group Date of Visit Assessment performed physician.
Supplementary Prescribing in a neonatal ICU
RAD Immunosuppression in Heart Transplant Recipients Duke Heart Failure Research Pager:
A RandomizEd Trial of ENtERal Glutamine to MinimIZE Thermal Injury: A multicenter Pragmatic RCT (definitive study) Study Sponsor Dr. Daren Heyland Clinical.
A RandomizEd Trial of ENtERal Glutamine to MinimIZE Thermal Injury: A multicenter Pragmatic RCT (definitive study) Study Sponsor Dr. Daren Heyland Clinical.
Medidata Rave Start-Up Information
Agents Intervening against Delirium in Intensive Care Unit (AID-ICU): An international inception cohort study AID-ICU Primary investigator: Marie Oxenboell-Collet.
ImageKids Study May  Contact Info………(3)  Basic Info…………(4)  Log In……………..(7)  Enrolment………...(10)  Clinical Data Entry.(34)  Blood Work……….(47)
TIPS FOR COMPLETING CRF’S October Antimicrobial Report Form 7  In iDataFax use the drop-down list to record the Antimicrobial Code. This will.
The First 400 Patients PROSPECT Meeting June 13, 2016 Jennie Johnstone, MD, PhD, FRCPC St. Joseph’s Health Center Public Health Ontario.
Søren Marker Jensen, MD, coordinating investigator
Agents Intervening against Delirium in Intensive Care Unit (AID-ICU): An international inception cohort study Primary investigator: Marie Oxenboell-Collet.
September 2016 Survey Data Entry User Guide (v1 – 6th September 2016)
Agents Intervening against Delirium in Intensive Care Unit (AID-ICU): An international inception cohort study Primary investigator: Marie Oxenboell-Collet.
Copenhagen University Hospital Rigshospitalet, Denmark
HOW TO ENTER BASELINE DATA
Agents Intervening against Delirium in Intensive Care Unit (AID-ICU): An international inception cohort study Primary investigator: Marie Oxenboell-Collet.
Safety Reporting Nichol McBee, MPH, CCRP.
The REDOXS© Study REducing Deaths from OXidative Stress Part 1 of 3
Protocol References Section Title 6.2 Entry Visit 5.1
Protocol References Section Title 6.2 Entry Visit 5.1
22 MAY – 5 JUNE 2017 A South African national, multi-centre fourteen day evaluation of patient care and clinical outcomes for paediatric patients undergoing.
Protocol Review July 8, 2016 Katie Oldmixon, RN MGH DCC
Protocol Review July 8, 2016 Katie Oldmixon, RN MGH DCC
ARCADIA Coordinator Webinar
The Effect of Higher Protein Dosing in Critically ill Patients: A Multicentre Registry-based Randomized Trial Timelines: Patients are to be screened and.
PROPPR Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma. 
HOW TO ENTER BASELINE DATA
Consent Training Module
Observational Studies vs. Randomized Controlled Trials (RCT)
BACKGROUND The optimal timing of RRT initiation in critically ill patients with AKI is still uncertain No consensus to guide clinical practice of acute.
Copenhagen University Hospital Rigshospitalet, Denmark
Telithromycin 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia  C. Carbon, S. Moola,
The REDOXS© Study REducing Deaths from OXidative Stress PART 2 of 4
E-CRF Overview Oracle® Clinical Remote Data Capture Training (Version 4.6 HTML) e-CRF Completion John McDonach Manager CDM, PPD.
Critical Care Tri Network Clinical Forum
The REDOXS© Study REducing Deaths from OXidative Stress PART 3 of 4
Module 4: Central Randomization System (CRS)
Serious Adverse Event Reconciliation
Presentation transcript:

Case Report Form Start-up Meeting March 25, 2010 Kingston, ON

Formats Web-based Central Randomization System (CRS) Web-based Central Randomization System (CRS) (Includes screening, pre-randomization and randomization) (Includes screening, pre-randomization and randomization) Paper-Based Case Report Form Paper-Based Case Report Form (Includes baseline, daily data, antibiotics, microbiology, study intervention, mechanical ventilation, infection adjudication and outcomes) (Includes baseline, daily data, antibiotics, microbiology, study intervention, mechanical ventilation, infection adjudication and outcomes)

Central Randomization System Logs all screened patients Randomizes eligible, consented patients Pharmacy access to prepare study treatment

Central Randomization Process SCREEN NEW PATIENT Does NOT meet all Inclusion Criteria. Will NOT be saved on CRS Form 1 Inclusion Criteria Form 2 Exclusion Criteria Patient Eligible Form 3 Pre-Randomization Meets at least one exclusion criteria. Data entry complete. Consent NOT obtained. Enter reason why. Data entry complete. Form 4 Randomization

CRF pg. 4-5

CRF pg. 6-7

CRF pg. 8-9 Pre-Randomization—Consent = Yes Pre-Randomization—Consent = No

Randomization CRF pg

Paper-Based CRF Once the patient has been randomized, all subsequent data collected should be entered onto the paper-based CRF Once the patient has been randomized, all subsequent data collected should be entered onto the paper-based CRF Instructions Data Entry Page

CRF pg

CRF pg To be collected within the first 24 hours of ICU admission

To be collected from Study Day 1 until ICU discharge, death or 28 days post randomization. Exception: Patient discharged to the ward < 14 days from randomization, continue until end of study day 14 CRF pg

CRF pg To be collected from Study Day 1 until ICU discharge, death or 28 days post randomization. Exception: Patient discharged to the ward < 14 days from randomization, continue until end of study day 14

To be collected from Study Day 1 until Day 14 (unless patient dies or is discharged from hospital. CRF pg

Protocol Violations Started open-label antifungal therapy Started open-label antifungal therapy Dosing error Dosing error Accidental unblinding Accidental unblinding Dose missed Dose missed Partial dose received Partial dose received Other, please specify Other, please specify

CRF pg To be collected from Study Day 1 until Day 14 (unless patient dies or is discharged from hospital. Should be reported to the Project Leader in “real time.”

CRF pg To be collected on Study Days 1, 3, 8 & 14.

CRF pg To be collected if: Initiated within 7 days of randomization Started in the ICU and continued in the ICU Started in ICU and continue past ICU discharge For patients receiving study treatment on the ward, collect until Study Day 17

CRF pg Do NOT record cultures that are NO GROWTH or CONTAMINANT Do NOT record SWABS To be collected if: Culture taken within 7 days of randomization Taken in the ICU For patients receiving study treatment on the ward, collect cultures taken until the end of Study Day 17

CRF pg If patient extubated < 48 hours, then mechanical ventilation is re-initiated, it is considered a continuation of previous ventilation.

CRF pg If patient discharged from ICU, then re-admitted within 48 hours, the re-admission is considered a continuation of the previous ICU stay.

Newly Acquired Hospital Infection Adjudication Site Investigator to make determination of a newly acquired infection based on antibiotic and microbiology data

Algorithm for Newly Acquired Infection Adjudication

If antibiotics started > 72 hr from randomization, 2 questions will be asked to help determine suspicion of hospital acquired infection

Suspicion of Hospital Acquired Infection 1. Is this antibiotic prescribed for prophylaxis? 2. Is this a substitute for an antibiotic previously ordered for an infection that occurred within 72 hrs of randomization? “NO” to both questions CLINICAL SUSPICION OF INFECTION Need Adjudication performed by Investigator or MD Delegate

If culture taken > 72 hr from randomization, 1 question will be asked to help determine suspicion of hospital acquired infection

Suspicion of Hospital Acquired Infection 1. Is this organism a manifestation of an infection that occurred within the first 72 hrs of randomization? “NO” to question CLINICAL SUSPICION OF INFECTION Need Adjudication performed by Investigator or MD Delegate

CRF pg Infection Adjudication Needs to be done for every suspicion that is triggered by an antibiotic or organism Categories of Infection & associated definitions found in Appendix 5

Is there an Infection? CRF pg. 34 This suspicion has already been adjudicated. 5 YES to Infection Refer to categories of infection for definitions of Definite, Probable & Possible 0 1 NO to Infection Indicate whether Probable or Possible NO

YES to Infection CRF Appendix 5

NO to Newly Acquired Infection

CRF pg

CRF pg

CRF pg